Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 1/2016

09.04.2015 | Correspondence

Development of Acute Promyelocytic Leukemia in a Patient With Gouty Arthritis on Long Term Colchicine

verfasst von: Nurhilal Buyukkurt, Asli Korur, Can Boga

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Sonderheft 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Colchicine is a frequently used drug in rheumatological diseases. Acute promyelocytic leukemia developed in a patient who used colchicine for gouty arthritis since 10 years is presented and the possible relation between the long term use of colchicine and hematological malignancies is discussed.
Literatur
1.
Zurück zum Zitat Ozdogu H, Boga C, Yılmaz Z, Sahin FI, Bal N (2007) Long-term colchicine therapy in a patient with Behçet’s disease and acute promyelocytic leukemia. Rheumatol Int 27:763–765CrossRefPubMed Ozdogu H, Boga C, Yılmaz Z, Sahin FI, Bal N (2007) Long-term colchicine therapy in a patient with Behçet’s disease and acute promyelocytic leukemia. Rheumatol Int 27:763–765CrossRefPubMed
2.
Zurück zum Zitat Kuo CF, Luo SF, See LC, Chou IJ, Fang YF, Yu KH (2012) Increased risk of c ancer among gout patients; a nationwide population study. Joint Bone Spine 79(4):375–378CrossRefPubMed Kuo CF, Luo SF, See LC, Chou IJ, Fang YF, Yu KH (2012) Increased risk of c ancer among gout patients; a nationwide population study. Joint Bone Spine 79(4):375–378CrossRefPubMed
3.
Zurück zum Zitat Ramadan SM, Fouad TM, Summa V, Hasan SKH, Lo-Coco F (2012) Acute myeloid leukemia developing in patients with autoimmune diseases. Haematologica 97:805–817CrossRefPubMedPubMedCentral Ramadan SM, Fouad TM, Summa V, Hasan SKH, Lo-Coco F (2012) Acute myeloid leukemia developing in patients with autoimmune diseases. Haematologica 97:805–817CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Krishnan E, Chen L (2013) Trends in physician diagnosed gout and gout therapies in the US: results from the national ambulatory health care surveys 1993 to 2009. Arthritis Res Ther 15:R181CrossRefPubMedPubMedCentral Krishnan E, Chen L (2013) Trends in physician diagnosed gout and gout therapies in the US: results from the national ambulatory health care surveys 1993 to 2009. Arthritis Res Ther 15:R181CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Bryce SM, Avlasevich SL, Bemis JC, Phonethepswath S, Dertinger SD (2010) Miniaturized flow cytometric in vitro micronucleus assay represents an efficient tool for comprehensively characterizing genotoxicity dose-response relationships. Mutat Res 703:191–199CrossRefPubMedPubMedCentral Bryce SM, Avlasevich SL, Bemis JC, Phonethepswath S, Dertinger SD (2010) Miniaturized flow cytometric in vitro micronucleus assay represents an efficient tool for comprehensively characterizing genotoxicity dose-response relationships. Mutat Res 703:191–199CrossRefPubMedPubMedCentral
Metadaten
Titel
Development of Acute Promyelocytic Leukemia in a Patient With Gouty Arthritis on Long Term Colchicine
verfasst von
Nurhilal Buyukkurt
Asli Korur
Can Boga
Publikationsdatum
09.04.2015
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe Sonderheft 1/2016
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-015-0523-4

Weitere Artikel der Sonderheft 1/2016

Indian Journal of Hematology and Blood Transfusion 1/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.